In recent years, as the pivotal role of inflammatory mechanisms in CVD has become increasingly apparent, research has shifted its focus toward the activation of inflammasomes, particularly NLRP3 inflammasome, and their involvement in the pathogenesis of atherosclerosis, myocardial ischemia-reperfusion injury, and heart failure. The gene discussed is NLRP3; the disease is atherosclerosis.